Dr. Carlos R Becerra
Claim this profileGSK Investigational Site
Studies Solid Tumors
Studies Tumors
6 reported clinical trials
10 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
KRAS positive
2Tumors
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Carlos R Becerra is currently running
FL115
for Cancer
First-in-Human, Phase I, open-label, multicenter, dose-escalation study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary antitumor activity of FL115 in patients with advanced solid tumors who have progressed or are intolerant to current standard-of-care therapies, including immune check-point inhibitors administered in single-agent or combination use.
Recruiting1 award Phase 112 criteria
TSR-022
for Cancer
This trial is testing TSR-022, a new medicine that helps the immune system fight cancer by blocking a protein called TIM-3. TIM-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that blocking TIM-3 with other treatments enhances the body's ability to fight tumors and suppress their growth. It targets patients with tumors, especially those who may not respond to standard treatments. The goal is to see if this medicine can help the immune system better attack cancer cells.
Recruiting1 award Phase 1
More about Carlos R Becerra
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Carlos R Becerra has experience with
- TSR-022
- Isunakinra
- PD-(L)1 Inhibitor
- HC-5404-FU
- NT-112
- FL115
Breakdown of trials Carlos R Becerra has run
Renal Cell Carcinoma
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carlos R Becerra specialize in?
Carlos R Becerra focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Carlos R Becerra currently recruiting for clinical trials?
Yes, Carlos R Becerra is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Carlos R Becerra has studied deeply?
Yes, Carlos R Becerra has studied treatments such as TSR-022, Isunakinra, PD-(L)1 Inhibitor.
What is the best way to schedule an appointment with Carlos R Becerra?
Apply for one of the trials that Carlos R Becerra is conducting.
What is the office address of Carlos R Becerra?
The office of Carlos R Becerra is located at: GSK Investigational Site, Dallas, Texas 75246 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.